Form 4 Filing for IMMUCELL CORP /DE/

Paul R. Wainman, a director at IMMUCELL CORP /DE/, was granted 10,000 Non-Qualified Stock Options on April 16, 2025. These options have an exercise price of $5.49 per share and are set to expire on April 16, 2030. The options were granted as compensation for services rendered on the board of directors. Following this transaction, Mr. Wainman holds 10,000 shares. The underlying security for these options is IMMUCELL CORP /DE/ Common Stock. The filing was made on April 14, 2026, and reported on Form 4.